These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11911255)

  • 21. Effect of short-term administration of N-(4-hydroxyphenyl)-all-trans-retinamide on chemically induced mammary tumors.
    Silverman J; Katayama S; Radok P; Levenstein MJ; Weisburger JH
    Nutr Cancer; 1983; 4(3):186-91. PubMed ID: 6221232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
    Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
    Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism.
    Lewis KC; Zech LA; Phang JM
    Cancer Res; 1994 Aug; 54(15):4112-7. PubMed ID: 8033144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Takahashi N; Sausville EA; Breitman TR
    Clin Cancer Res; 1995 Jun; 1(6):637-42. PubMed ID: 9816026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
    Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer.
    Tokar EJ; Ancrile BB; Ablin RJ; Webber MM
    J Exp Ther Oncol; 2006; 5(4):323-33. PubMed ID: 17024972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
    Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
    Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
    Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M
    Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N; Koibuchi Y; Iino Y; Morishita Y
    Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
    Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-carcinogenic and anti-blastic effect of vitamin A in various modes of its administration to random-bred rats during carcinogenesis of the mammary gland, induced by 7,12-dimethylbenz(a)anthracene].
    Piatchanina TV; Kartavova NS; Gutnik NS; Sidorik EP
    Eksp Onkol; 1989; 11(5):20-3. PubMed ID: 2507271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
    Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
    Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative activity of dietary or topical exposure to three retinoids in the promotion of skin tumor induction in mice.
    McCormick DL; Bagg BJ; Hultin TA
    Cancer Res; 1987 Nov; 47(22):5989-93. PubMed ID: 2959358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-(4-hydroxyphenyl)-retinamide increases lecithin:retinol acyltransferase activity in rat liver.
    Matsuura T; Zhao Z; Ross AC
    J Nutr; 1996 Oct; 126(10):2474-80. PubMed ID: 8857507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients.
    Formelli F; Cavadini E; Luksch R; Garaventa A; Appierto V; Persiani S
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):993-8. PubMed ID: 20532509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells.
    Bunk MJ; Kinahan JJ; Sarkar NH
    Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye.
    Lewis KC; Zech LA; Phang JM
    Eur J Cancer; 1996 Sep; 32A(10):1803-8. PubMed ID: 8983293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
    Kurie JM; Lee JS; Khuri FR; Mao L; Morice RC; Lee JJ; Walsh GL; Broxson A; Lippman SM; Ro JY; Kemp BL; Liu D; Fritsche HA; Xu X; Lotan R; Hong WK
    Clin Cancer Res; 2000 Aug; 6(8):2973-9. PubMed ID: 10955773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.